|
Development of effective healthcare products demands an in depth understanding of a particular disease at the molecular level.
Having such knowledge in hand enables identification of mechanisms, targets and markers specific for a disease - and such molecular
content provides the ground for improved diagnostics and therapy products.
emergentec's mission is to discover innovative molecular CONTENT in the CONTEXT of unmet clinical needs, and to develop these
biomarkers and targets into improved diagnostics and therapy products.
|